Sameek Roychowdhury Department of Internal Medicine, Division of Medical Oncology, Comprehensive Cancer Center The Ohio State University Biography Publications Institution JoVE Articles Sameek Roychowdhury has not added a biography. If you are Sameek Roychowdhury and would like to personalize this page please email our Author Liaison for assistance. Publications The Bayesian Basket Design for Genomic Variant-driven Phase II Trials Seminars in Oncology. Feb, 2016 | Pubmed ID: 26970120 Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories Journal of the National Cancer Institute. Apr, 2016 | Pubmed ID: 26590952 Translating Cancer Genomes and Transcriptomes for Precision Oncology CA: a Cancer Journal for Clinicians. Jan-Feb, 2016 | Pubmed ID: 26528881 Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth JAMA. Sep, 2015 | Pubmed ID: 26325560 Cancer Driver Log (CanDL): Catalog of Potentially Actionable Cancer Mutations The Journal of Molecular Diagnostics : JMD. Sep, 2015 | Pubmed ID: 26320871 Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing Human Mutation. Sep, 2015 | Pubmed ID: 26110913 Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer Medicine American Society of Clinical Oncology Educational Book / ASCO. American Society of Clinical Oncology. Meeting. 2015 | Pubmed ID: 25993170 Comparison of Custom Capture for Targeted Next-generation DNA Sequencing The Journal of Molecular Diagnostics : JMD. Jan, 2015 | Pubmed ID: 25528188 Translating Genomics for Precision Cancer Medicine Annual Review of Genomics and Human Genetics. 2014 | Pubmed ID: 25184532 Clinical Tumor Sequencing: an Incidental Casualty of the American College of Medical Genetics and Genomics Recommendations for Reporting of Incidental Findings Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2014 | Pubmed ID: 24958819 Activating ESR1 Mutations in Hormone-resistant Metastatic Breast Cancer Nature Genetics. Dec, 2013 | Pubmed ID: 24185510 Implementing Personalized Cancer Genomics in Clinical Trials Nature Reviews. Drug Discovery. May, 2013 | Pubmed ID: 23629504 Advancing Precision Medicine for Prostate Cancer Through Genomics Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2013 | Pubmed ID: 23589550 Identification of Targetable FGFR Gene Fusions in Diverse Cancers Cancer Discovery. Jun, 2013 | Pubmed ID: 23558953 Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing Nature Genetics. Feb, 2013 | Pubmed ID: 23313952 Personalized Oncology Through Integrative High-throughput Sequencing: a Pilot Study Science Translational Medicine. Nov, 2011 | Pubmed ID: 22133722 Managing Resistance in Chronic Myeloid Leukemia Blood Reviews. Nov, 2011 | Pubmed ID: 21982419 Trans-presentation of Donor-derived Interleukin 15 is Necessary for the Rapid Onset of Acute Graft-versus-host Disease but Not for Graft-versus-tumor Activity Blood. Oct, 2006 | Pubmed ID: 16757683 Cytokine Therapy for Cancer: Antigen Presentation Cancer Treatment and Research. 2005 | Pubmed ID: 16211874 IL-15 but Not IL-2 Rapidly Induces Lethal Xenogeneic Graft-versus-host Disease Blood. Oct, 2005 | Pubmed ID: 15976176 A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56bright Natural Killer Cells Immunity. Mar, 2005 | Pubmed ID: 15780987 IFN-gamma Gene Polymorphisms Associate with Development of EBV+ Lymphoproliferative Disease in Hu PBL-SCID Mice Blood. Feb, 2005 | Pubmed ID: 15498860 Anti-human CTLA-4 Monoclonal Antibody Promotes T-cell Expansion and Immunity in a Hu-PBL-SCID Model: a New Method for Preclinical Screening of Costimulatory Monoclonal Antibodies Blood. Feb, 2005 | Pubmed ID: 15486062 Donor-derived IL-15 is Critical for Acute Allogeneic Graft-versus-host Disease Blood. Jan, 2005 | Pubmed ID: 15374888 Failed Adoptive Immunotherapy with Tumor-specific T Cells: Reversal with Low-dose Interleukin 15 but Not Low-dose Interleukin 2 Cancer Research. Nov, 2004 | Pubmed ID: 15520217 Selective Efficacy of Depsipeptide in a Xenograft Model of Epstein-Barr Virus-positive Lymphoproliferative Disorder Journal of the National Cancer Institute. Oct, 2004 | Pubmed ID: 15467034 Combination Immunotherapy of B-cell Non-Hodgkin's Lymphoma with Rituximab and Interleukin-2: a Preclinical and Phase I Study Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2004 | Pubmed ID: 15447996 Experimental Treatment of Epstein-Barr Virus-associated Primary Central Nervous System Lymphoma Cancer Research. Mar, 2003 | Pubmed ID: 12615710 Successful Treatment of Posttransplantation Lymphoproliferative Disorder (PTLD) Following Renal Allografting is Associated with Sustained CD8(+) T-cell Restoration Blood. Oct, 2002 | Pubmed ID: 12239141 RNA-Sequenzierung Assay Gezieltes Genexpression und Genomic Änderungen an Charakterisieren Dorrelyn P. Martin1, Jharna Miya1, Julie W. Reeser1, Sameek Roychowdhury1,2 1Department of Internal Medicine, Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University, 2Department of Pharmacology, The Ohio State University Biology
RNA-Sequenzierung Assay Gezieltes Genexpression und Genomic Änderungen an Charakterisieren Dorrelyn P. Martin1, Jharna Miya1, Julie W. Reeser1, Sameek Roychowdhury1,2 1Department of Internal Medicine, Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University, 2Department of Pharmacology, The Ohio State University Biology
